Breast Cancer

For patients with metastatic breast cancer, “Involving palliative care as an active member of your oncology team early on is one of the smartest things you can do,” says national expert and breast cancer survivor Lillie Shockney.

For those dealing with metastatic breast cancer, national expert and breast cancer survivor Lillie Shockney stresses the importance of celebrating milestone events and joyful moments during treatment.

The CDK4/CDK6 inhibitor Verzenio received a new indication, for use alone or in combination with an aromatase inhibitor, as initial therapy in women with HR-positive, HER2-negative advanced or metastatic breast cancer.

A national advocacy program trains patients with metastatic breast cancer to educate the public about the special needs of patients with advanced breast cancer.

Dr Hayes, Immediate Past President of ASCO and Professor of Breast Cancer Research at the University of Michigan Comprehensive Cancer Center, explains how biomarkers offer more precise treatment opportunities for patients with breast cancer.

Musa Mayer, breast cancer survivor and advocate, was recently recognized for her 25 years of advocacy on behalf of patients with advanced breast cancer. Read Musa’s inspiring story.

Hundreds of people with metastatic breast cancer and their caregivers from across the country will attend the 2018 Conference on Metastatic Breast Cancer in Philadelphia on April 20–22, 2018, hosted by Living Beyond Breast Cancer.

NeuVax + Herceptin may provide a clinically meaningful benefit to breast cancer patients with low to intermediate HER2-expression.

In patients with HR-positive breast cancer, a positive circulating tumor cells assay result was associated with nearly a 20-fold increased risk for recurrence of disease.